The consideration of patient preferences in decision‐making has become more important,
especially for life‐threatening diseases such as lung cancer. This paper aims to identify the …

Background Regulatory agencies as well as private organizations pursue programs that
advocate patient centricity and emphasize the importance of dialog with patients. Various …

Background In the treatment of Non-Small Cell Lung Cancer (NSCLC) the combination of
Immuno-Oncotherapy (IO) and chemotherapy (CT) has been found to be superior to IO or CT …

Background Lung cancer is one of the most common types of cancer worldwide, and it
causes significant challenges for patients due to the poor survival rate and treatment‐related …

BACKGROUND: Treatment decisions for advanced non-small cell lung cancer (NSCLC) are
complex and require trade-offs between the benefits and risks experienced by patients. We …

Objective Lung cancer is a major cause of cancer-related deaths and thus represents a
global health problem. According to World Health Organization (WHO) estimates …

Objectives There is increasing interest in studies that examine patient preferences to
measure health-related outcomes. Understanding patients' preferences can improve the …

Introduction: Lung cancer is the deadliest and most prevalent cancer worldwide. Lung
cancer treatments have different characteristics and are associated with a range of benefits …

Purpose The purpose of this study is to review the literature examining how the beliefs and
behaviours of physicians and patients influence clinical communication, doctor–patient …

Objective Increased treatment options and longer survival for lung cancer have generated
increased interest in patient preferences. Previous studies of patient preferences in lung …